Nanobebe US Inc. v. Mayborn (UK) Limited

CourtDistrict Court, S.D. New York
DecidedFebruary 6, 2023
Docket1:21-cv-08444
StatusUnknown

This text of Nanobebe US Inc. v. Mayborn (UK) Limited (Nanobebe US Inc. v. Mayborn (UK) Limited) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nanobebe US Inc. v. Mayborn (UK) Limited, (S.D.N.Y. 2023).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK NANOBEBE US INC., Plaintiff, -against- 21-cv-08444 (JLR) MAYBORN (UK) LIMITED et al., ORDER Defendants.

JENNIFER L. ROCHON, United States District Judge:

On February 1, 2023, Plaintiff Nanobebe US Inc. (“Nanobebe”) requested an adjournment of the February 22, 2023 Markman hearing because it intends to file a motion to stay based on two related inter partes review (“IPR”) proceedings. ECF No. 67. Defendants Mayborn (UK) Limited et al. (“Mayborn”) opposed this request for an adjournment of the Markman hearing (and the proposed motion to stay). ECF No. 68. This case has been pending since October 13, 2021. ECF No. 1. Discovery has been conducted. ECF No. 68 at 3. Claim construction briefing has already been extended due to the replacement of counsel for Nanobebe (ECF No. 51) and the Markman hearing has also been rescheduled once (ECF No. 61). Claim construction has been fully briefed since November 30, 2022; the parties conducted two technology tutorials due to the reassignment of this case; and, the February 22, 2023 Markman hearing has been scheduled since November 4, 2022. ECF No. 61. During the pendency of this case, third parties Comotomo, Inc. and Comotomo Corp. (collectively “Comotomo”), filed an IPR petition with the United States Patent and Trademark Office (“USPTO”) challenging the validity of the claims of the ‘930 and ‘244 Patents, the patents at issue in this case. ECF No. 67 at 1. On January 24, 2023, the USPTO granted Comotomo’s IPR petition as to the ‘930 Patent and denied the IPR petition as to the ‘244 Patent. Id. According to Mayborn, the Board granted the petition and instituted the review solely to address whether claim 13 of the ‘930 Patent is invalid and, given this, Mayborn asserts that Comotomo has offered to withdraw the instituted IPR. ECF No. 68 at 1-2. Claim 13 is not at issue in the present patent infringement action. ECF No. 45. Nanobebe stated in its joint letter to the Court on October 14, 2022 that it was preparing its request for an IPR petition with the USPTO and was “likely to file that request shortly.” ECF No. 58 at 7. Nanobebe did not ultimately file its request for an IPR petition until January 12, 2023 – the last day before its IPR petition would be statutorily barred, according to Mayborn. ECF No. 68 at 2. The USPTO has until July 12, 2023 to make an institution decision with respect to Nanobebe’s request and, if instituted, has additional time to make a final decision. ECF No. 67 at 2. The Court is unclear as to why Nanobebe waited until January 12, 2023 to file its IPR request;

Nanobebe did not file its request to adjourn the Markman hearing until February 1, 2023; and it still has not filed its motion to stay. The Court will not adjourn the Markman hearing. See Sequa Corp. v. GBJ Corp., 156 F.3d 136, 147-48 (2d Cir. 1998) (district court has discretion as to whether to adjourn hearings). There have already been several extensions of various deadlines and adjournments in this case. The Markman hearing has been scheduled since November 2022 and the Court and parties have been preparing for it, including through the recent technology tutorial on January 18, 2022. The Court will evaluate any motion to stay that is filed by Nanobebe but notes that, at this point, an uninstituted IPR petition request would not seem to support a stay of an action between two direct competitors. See, e.g., CDX Diagnostics, Inc. v. U.S. Endoscopy Grp., Inc., 2014 WL 2854656 (NSR), at *4 (S.D.N.Y. June 14, 2014) (holding that uninstituted petition did not weigh in favor of a stay because “although IPR proceedings may serve to narrow the issues in the pending litigation, it is unclear at this stage whether the PTO will institute proceedings on any or all of the petitions”); Rensselaer Polytechnic Inst. v. Apple Inc., 2014 WL 201965 (DEP), at *6 (N.D.N.Y. Jan. 15, 2014) (“[u]ntil the PTO acts on the pending petition, the court is unable to assess with precision the extent, if at all, to which a decision on the petitions may serve to simplify the issues of this case”). The Markman hearing will proceed as scheduled on February 22, 2023. Dated: February 6, 2023 New York, New York SO ORDERED. here L. ROCHON United States District Judge

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sequa Corp. v. GBJ Corp.
156 F.3d 136 (Second Circuit, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
Nanobebe US Inc. v. Mayborn (UK) Limited, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nanobebe-us-inc-v-mayborn-uk-limited-nysd-2023.